MedDay annonce un symposium satellite et présente des données supplémentaires sur le MD1003 dans la sclérose en plaques progressive lors du congrès ECTRIMS-ACTRIMS
October 26, 2017 01:02 ET
|
MEDDAY PHARMACEUTICALS SA
MedDay annonce un symposium satellite et présente des données supplémentaires sur le MD1003 dans la sclérose en plaques progressive lors du congrès ECTRIMS-ACTRIMS Présence de MedDay au stand D30...
MedDay Sponsors Satellite Symposium Today and Presents Additional Data on MD1003 in Progressive Multiple Sclerosis at ECTRIMS-ACTRIMS Meeting
October 26, 2017 01:02 ET
|
MEDDAY PHARMACEUTICALS SA
MedDay Sponsors Satellite Symposium Today and Presents Additional Data on MD1003 in Progressive Multiple Sclerosis at ECTRIMS-ACTRIMS Meeting MedDay is exhibiting at Booth D30 during the meeting...
MedDay to Participate in the 7th Joint ECTRIMS - ACTRIMS Meeting in Paris, France
October 18, 2017 01:00 ET
|
MEDDAY PHARMACEUTICALS SA
MedDay to Participate in the 7th Joint ECTRIMS - ACTRIMS Meeting in Paris, France Sponsors a satellite symposium: 'New horizons in progressive multiple sclerosis' Oral presentation of 24-month...
MedDay Boosts its Research Capabilities with Profilomic Acquisition
March 06, 2017 09:32 ET
|
MEDDAY PHARMACEUTICALS SA
MedDay Boosts its Research Capabilities with Profilomic Acquisition ~Acquisition of Profilomic SA health division fuels the growth of MedDay~ Paris, France, 6 March 2017 - MedDay, a...
MEDDAY PHARMACEUTICALS SA: Strengthens its Board with Two Senior Non-Executive Directors
September 29, 2016 02:14 ET
|
MEDDAY PHARMACEUTICALS SA
PARIS, Sept. 29, 2016 (GLOBE NEWSWIRE) -- MedDay, a biotechnology company focused on the treatment of nervous system disorders, is today pleased to announce the appointment of Janet Vergis and George...